Gregory T. Went, Chief Executive Officer, 10% Owner at Adamas Pharmaceuticals Inc (ADMS), sold 14,757 shares at $1.88 ($106K) on 2015-04-14, disclosed to the SEC on 2015-04-14.
Scheduled sale ($106k) by Chief Executive Officer, 10% Owner under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $18.09 | 900 | $16K | 15.4% |
| 2 | $18.16 | 3,077 | $56K | 52.9% |
| 3 | $19.00 | 100 | $2K | 1.8% |
| 4 | $19.07 | 500 | $10K | 9.0% |
| 5 | $1.88 | 10,000 | $19K | 17.8% |
| 6 | $18.00 | 80 |
| $1K |
| 1.4% |
| 7 | $18.00 | 100 | $2K | 1.7% |
| Total | $7.16 avg | 14,757 | $106K | 100% |
| Filing → |
| ADMS | SELL | 2018-03-22 | $234K | — | Filing → |
| ADMS | SELL | 2017-03-22 | $48K | — | Filing → |
| ADMS | SELL | 2015-05-14 | $49K | — | Filing → |